MetLife Investment Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,701
Closed -$169K 2818
2024
Q3
$169K Sell
16,701
-336
-2% -$2.18K ﹤0.01% 2369
2024
Q2
$76.7K Buy
17,037
+6,391
+60% +$65K ﹤0.01% 2691
2024
Q1
$159K Hold
10,646
﹤0.01% 2318
2023
Q4
$155K Hold
10,646
﹤0.01% 2379
2023
Q3
$146K Hold
10,646
﹤0.01% 2374
2023
Q2
$234K Buy
+10,646
New +$333K ﹤0.01% 2179

Other funds holding BMEA

MetLife Investment Management's BMEA Position: Q4 2024 in Review

MetLife Investment Management sold out of Biomea Fusion (BMEA) in Q4 2024, closing a stake of 16,701 shares — an estimated $169K sold.

MetLife Investment Management first reported a position in BMEA in Q2 2023 and held it in 6 quarters. The position peaked at $234K in Q2 2023. 108 funds tracked by Wall St. Rank hold BMEA as of Q4 2024.

  • MetLife Investment Management reported no remaining Biomea Fusion position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 16,701 Biomea Fusion shares in Q4 2024, an estimated $169K.
  • MetLife Investment Management first reported a position in Biomea Fusion in Q2 2023 and held it in 6 quarters.
  • MetLife Investment Management's Biomea Fusion position peaked at $234K in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.